Show Summary Details

Page of

PRINTED FROM OXFORD HANDBOOKS ONLINE ( © Oxford University Press, 2018. All Rights Reserved. Under the terms of the licence agreement, an individual user may print out a PDF of a single chapter of a title in Oxford Handbooks Online for personal use (for details see Privacy Policy and Legal Notice).

date: 10 April 2021

Abstract and Keywords

Nonmedical use of prescription drugs can pose a variety of serious public health threats. Rapid increases in the use of prescription drugs were observed at the turn of the 21st century and prompted new research and several actions by communities and policymakers. Adolescents and young adults are at heightened risk for this type of substance use. The evidence suggests that nonmedical use of prescription drugs overlaps significantly with alcohol and other drug problems, and it might be a sign of more severe involvement with illicit substance use. This chapter describes the epidemiology, availability and sources, motives, risk factors, and consequences of nonmedical prescription drug use among adolescents and young adults. Special topics include nonmedical use of prescription stimulants and academic performance, associations with attention-deficit/hyperactivity disorder and mental health, and diversion behavior. Future directions for research and strategies for demand and supply reduction are described.

Keywords: nonmedical use, medications, diversion, stimulants, analgesics, sedatives, tranquilizers, anxiolytics, medications, academic performance

Access to the complete content on Oxford Handbooks Online requires a subscription or purchase. Public users are able to search the site and view the abstracts and keywords for each book and chapter without a subscription.

Please subscribe or login to access full text content.

If you have purchased a print title that contains an access token, please see the token for information about how to register your code.

For questions on access or troubleshooting, please check our FAQs, and if you can''t find the answer there, please contact us.